Prevalence, antimicrobial susceptibility patterns, serotypes and risk factors for group B streptococcus rectovaginal isolates among pregnant women at Kenyatta National Hospital, Kenya; a cross-sectional study
Open Access
- 22 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 20 (1), 1-9
- https://doi.org/10.1186/s12879-020-05035-1
Abstract
Background Estimates of Group B Streptococcus (GBS) disease burden, antimicrobial susceptibility, and serotypes in pregnant women are limited for many resource-limited countries including Kenya. These data are required to inform recommendations for prophylaxis and treatment of infections due to GBS. Methods We evaluated the prevalence, antimicrobial susceptibility patterns, serotypes, and risk factors associated with rectovaginal GBS colonization among pregnant women receiving antenatal care at Kenyatta National Hospital (KNH) between August and November 2017. Consenting pregnant women between 12 and 40 weeks of gestation were enrolled. Interview-administered questionnaires were used to assess risk factors associated with GBS colonization. An anorectal swab and a lower vaginal swab were collected and cultured on Granada agar for GBS isolation. Positive colonies were tested for antimicrobial susceptibility to penicillin G, ampicillin, vancomycin, and clindamycin using the disk diffusion method. Serotyping was performed by latex agglutination. Logistic regression was used to identify factors associated with GBS colonization. Results A total of 292 women were enrolled. Median age was 30 years (Interquartile range {IQR} 26-35) and a median gestational age of 35 weeks (IQR 30-37). Overall GBS was identified in 60/292 (20.5%) of participants. Among the positive isolates, resistance was detected for penicillin G in 42/58 (72.4%) isolates, ampicillin in 32/58 (55.2%) isolates, clindamycin in 14/46 (30.4%) isolates, and vancomycin in 14/58 (24.1%) isolates. All ten GBS serotypes were isolated, and 37/53 (69.8%) of GBS positive participants were colonized by more than one serotype. None of the risk factors was associated with GBS colonization. Conclusion The prevalence of GBS colonization was high among antenatal women at KNH. In addition, a high proportion of GBS isolates were resistant to commonly prescribed intrapartum antibiotics. Hence, other measures like GBS vaccination is a potentially useful approaches to GBS prevention and control in this population. Screening of pregnant mothers for GBS colonization should be introduced and antimicrobial susceptibility test performed on GBS positive samples to guide antibiotic prophylaxis.Other Versions
Funding Information
- National Research Fund of Kenya (not given)
This publication has 20 references indexed in Scilit:
- Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USAClinical Microbiology & Infection, 2017
- Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infantsJournal of Infection, 2016
- Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South AfricaBMC Research Notes, 2015
- Prevalence of colonization by Streptococcus agalactiae among pregnant women in Bukavu, Democratic Republic of the Congo.Journal of Infection in Developing Countries, 2014
- Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibilityBMC Infectious Diseases, 2014
- Clinical Evaluation of the Walk-Away Specimen Processor and ESwab for Recovery of Streptococcus agalactiae Isolates in Prenatal Screening SpecimensJournal of Clinical Microbiology, 2014
- Group B streptococcusserotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distributionBMC Infectious Diseases, 2010
- Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant womenBMC Infectious Diseases, 2010
- The prevalence and adverse effects of group B streptococcal colonization during pregnancy.2008
- Neonatal sepsis caused by a new group B streptococcal serotypeThe Journal of Pediatrics, 1993